Literaturliste
Bitte klicken Sie auf die Publikationen, um weitere Informationen zu erhalten.
2012:
Cohrs S, Rodenbeck A, Riemann D, Szagun B, Jaehne A, Brinkmeyer J, Gründer G, Wienker T, Diaz-Lacava A, Mobascher A, Dahmen N, Thuerauf N, Kornhuber J, Kiefer F, Gallinat J, Wagner M, Kunz D, Grittner U, Winterer G: Impaired Sleep Quality and Sleep Duration in Smokers- Results from the German Multicenter Study on Nicotine Dependence. Addiction Biology (IF: 4.2), in revision
Goerke M, Cohrs S, Rodenbeck A, Grittner U, Sommer W, Kunz D: Declarative memory consolidation during the first night in a sleep lab - The role of REM sleep and cortisol. Psychoneuroendocrinology (IF: 5.2), in revision
Kunz D, Bineau S, Maman K, Milea D, Tourni M: Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database. Espert Opin Pharmacother (IF: 2.4) 2012 Jan; 13(1): 9 - 16.
Hoever P, Dorffner G, Beneš H, Penzel T, Danker-Hopfe H, Barbanoj MJ, Pillar G, Saletu B, Polo O, Kunz D, Zeitlhofer J, Berg S, Partinen M, Bassetti CL, Högl B, Ebrahim IO, Holsboer-Trachsler E, Bengtsson H, Peker Y, Hemmeter U-M, Chiossi E, Hajak G, Dingemanse J: Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial. Clinical Pharmacology & Therapeutics (IF: 6.4), advanced online publication 2 May 2012
2011:
Rodenbeck A: Biologische Grundlagen des Schlafens und Wachens. Bundesgesundheitsblatt - 2011 54:1270–1275 DOI 10.1007/s0010301113733
Kunz D: Schlafstörungen und Depression: Melatonin taktet die innere Uhr neu. Neurologie & Psychiatrie 2012; Vol. 14, Nr. 1 (CME 01/2012)
2010:
Kozakov R, Schöpp H, Franke St, Stoll C, Kunz D: Modification of light sources for appropriate biological action. Journal of Physics D: Applied Physics (2010) 43: 234007
Kunz D, Mahlberg R: A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res. (2010) Jun 16 [Epub ahead of print]
Cohrs S, Gade K, Meier A, Jordan W, Falkai P, Rüther E, Rodenbeck A. Quetiapine improves sleep disturbance in acute bipolar disorder: a case series. Pharmacopsychiatry. (2010) Jun;43(4):154-5
Jähne A, Cohrs S, Rodenbeck A, Andreas S, Loessl B, Feige B, Kloepfer C, Hornyak M, Riemann D. Nikotin. Einfluss auf den Schlaf und Relevanz fur Psychiatrie und Psychotherapie.Nervenarzt. (2010) Jul;81(7):844-59
A. Rodenbeck, G. Hajak (2010): Das Schichtarbeitersyndrom. Eine systematische Übersicht zu Schlafstörungen durch Schichtarbeit. Somnologie Vol 14, Nr 2: 105-110
G. Hajak, A. Rodenbeck (2010): Medikamentöse Therapie des Schichtarbeitersyndroms. Somnologie Vol 14, Nr 2: 111-122
2009:
Gunga H-C, Werner A, Stahn A, Steinach M, Schlabs T, Koralewski E, Kunz D: The Double Sensor - A non-invasive device to continuously monitor core temperature in humans on earth and in space
Alpay G, Goerke M, Sturmer B (2009). Precueing imminent conflict does not override sequence-dependent interference adaptation. Psychological Research-Psychologische Forschung: 73: 803-816
G. Mayer, I Fietze, Fischer J, Penzel T, Riemann D, Rodenbeck A, Sitter H, Teschler H (2009). S3 Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 13, Suppl; 4.160
Bodenmann S, Rusterholz T, Dürr R, Stoll C, Bachmann V, Geissler E, Jaggi-Schwarz K, Landolt H-P. The Functional Val158Met Polymorphism of COMT
Predicts Interindividual Differences in Brain alpha Oscillations
in Young Men. J Neuroscience 29:10855-10862
Cohrs S (2009). Genese schlafassoziierter forensisch-relevanter Störungen. In: Müller, Jürgen, Peter (Hrsg.) Neurobiologie forensisch-relevanter Störungen, Kohlhammer, Stuttgart, S: 231 - 238
Rodenbeck A, Cohrs S, Zerr I (2009). Letale familiäre Insomnie. In: Happe S; Walther B W (Hrsg.) Schlafmedizin in der Praxis. Die internationale Klassifikation von Schlafstörungen in Fallberichten, ECOMED Medizin, Heidelberg, S: 355-360
Mahlberg R, Kienast T, Haedel S, Heidenreich JO, Schmitz S, Kunz D. Degree of Pineal Calcification (DOC) is Associated With Polysomnographic Sleep Measures in Primary Insomnia Patients. Sleep Medicine Sleep Med. 2009 Apr;10(4):439-45. Epub 2008 Aug 27
2008:
Brown SA, Kunz D, Dumas A, Westermark PO, Vanselow K, Wahnschaffe A, Herzel HP, Kramer A (2008) Molecular insights into human daily behavior. PNAS (IF: 9.6) 105:1602-1607.
Mahlberg R, Walther S, Kalus P, Bohner G, Haedel S, Reischies FM, Kühl KP, Hellweg R, Kunz D (2008). Pineal calcification in Alzheimer's disease: An in vivo study using computed tomography. Neurobiol Aging (IF: 5.6) 29:203-209.
Wedekind D, Preiss B, Cohrs S, Ruether E, Huether G, Adler L (2008) Relationship between nocturnal urinary cortisol excretion and symptom severity in subgroups of patients with depressive episodes. Neuropsychobiology (IF: 2,4) 56:119-22
Cohrs S (2008): Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics. CNS Drugs. CNS Drugs 22, 939-962
Rodenbeck A, Cohrs S (2008): Psychoneuroendokrinologie der Insomnie - Der Circulus vitiosus der psychophysiologischen Insomnie auf psychologischer, elektrophysiologischer und endokriner Ebene. psychoneuro 34, 63-68
Cohrs S, Rodenbeck A, Hornyak M, Kunz D (2008): Restless legs syndrom, periodische Gliedmaßenbewegungen im Schlaf und Psychopharmakologie, Nervenarzt. 2008 79, 1263-72
2007:
Gallinat J, Kunz D (both first authors contributed equally), Lang UE, Neu P, Kassim N, Kienast T, Seifert F, Schubert F, Bajbouj M (2007). Association between cerebral glutamate and human behaviour: The sensation seeking personality trait. Neuroimage (IF: 5.6) 34:671-67.
Mahlberg R, Kunz D (2007). Relationship of melatonin excretion levels to polysomnographic sleep parameters in healthy subjects and patients with sleep related disturbances. Sleep Medicine (IF: 2.9) 8:512-516.
Mahlberg R, Walther S, Eichmann U, Tracik F, Kunz D (2007). Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer’s Disease: A placebo-controlled pilot study. Arch Gerontol Geriatr (IF: 1.1) 45:19-26.
Montag C, Heinz A, Kunz D, Gallinat J (2007). Self-reported empathic abilities in schizophrenia. Schizophrenia Res. (IF: 4.3) 92:85-89.
2006:
Benes H, Deissler A, Rodenbeck A, Engfer A, Kohnen R (2006) Lisuride treatment of restless legs syndrome: First studies with monotherapy in de novo patients and in combination with levodopa in advanced disease. J Neural Transm (IF: 2,9)113:87-92
Cohrs S, Röher C, Jordan W, Meier A, Huether G, Wuttke W, Rüther E, Rodenbeck A (2006) The atypical antipsychotics olanzapine and quetiapine but not haloperidol reduce ACTH and cortisol. Psychopharmacology (IF: 3,6) 185 (1):11-18
Gallinat J, Kunz D (both first authors contributed equally), Senkowski D, Kienast T, Seifert F. Schubert F, Heinz A (2006). Hippocampal glutamate concentration predicts cerebral theta oscillations. Psychopharmacology (IF: 3.6) 187:103-111.
Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G, Pilz J, Rüther E, Kornhuber J, Bleich S (2006) Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm (IF: 2,9) 113: 239 – 254
Kluge M, Schussler P, Weikel J, Dresler M, Zuber V, Querfurt F, Yassouridis A, Steiger A. Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder. Psychoneuroendocrinology (IF: 3.0) 2006 31:1098-104.
Mahlberg R, Tilmann A, Salewski L, Kunz D (2006). Normative data on the daily profile of urinary 6-sulfatoxymelatonin in healthy subjects between the ages 20 and 84. Psychoneuroendocrinology (IF: 4.9) 31: 634-41.
Muller B, Gäbelein WD, Schulz H. A taxonomic analysis of sleep stages. Sleep (IF: 5.1) 2006 29:967-74.
Rodenbeck A, Binder R, Geisler P, Danker-Hopfe H, Lund R, Raschke F, Weeß HG, Schulz H (Task Force "Scoring of Polysomnographic Recordings" of the German Sleep Society [DGSM]) (2006) A Review of Sleep EEG Patterns. Part 1: A compilation of amended rules for their visual recognition according to Rechtschaffen and Kales. Somnologie (IF: 0,2) 10:159-175
Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel JC, Sonntag A, Steiger A (2006) Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin and leptin and the DEX-CRH-test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology (IF: 4.9) 31 (4):832-844.
Schmitz S, Heidenreich JO, Platzek I, Kunz D, Mahlberg R, Wolf KJ (2006). Computed tomography of the human pineal gland for study of the sleep-wake rhythm: Reproducibility of a semi-quantitative approach. Acta Radiologica (IF: 0.9) 47:865-871.
Schmidt H, Cohrs S, Heinemann T, Goerdt C, Djukic M, Heimann B, Wallesch CW, Nau R (2006) Sleep disorders are long-term sequelae of both bacterial and viral meningitis. J Neurol Neurosurg & Psychiatry (IF: 3,6) 77 (4): 554-558
Walther S, Mahlberg R, Eichmann U, Kunz D (2006). Delta-9-tetrahydrocannabinol for night-time agitation in severe dementia. Psychopharmacology (IF: 3.6) 185:524-8.
2005:
Anderer P, Gruber G, Parapatics S, Woertz M, Miazhynskaia T, Klösch G, Saletu B, Zeitlhofer J, Barbanoj MJ, Danker-Hopfe H, Himanen SL, Kemp B, Penzel T, Grözinger M, Kunz D, Rappelsberger P, Schlögl A, Dorffner G (2005). An E-Health Solution for Automatic Sleep Classification according to Rechtschaffen and Kales: Validation Study of the Somnolyzer 24x7 utilizing the Siesta Database. Neuropsychobiology (IF: 2.4) 51:115-33.
Cohrs S, Meier A, Neumann AC, Rüther E, Rodenbeck A (2005) Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects. J Clin Psychiatry (IF: 5,5) 66, 989-96
Gallinat J, Kunz D (both first authors contributed equally) , Lang UE, Kalus P, Juckel G, Mahlberg R, Eggers T, Wernicke C, Rommelspacher H, Smolka MN (2005). Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: Evidence from auditory cortical stimulus processing. Pharmacopsychiatry (IF: 2.8) 38:158-60.
Happe S, Klösch G, Lorenzo J, Kunz D, Penzel T, Röschke J, Himanen SL, Gruber, Zeitlhofer (2005). Perception of sleep: Subjective versus objective sleep parameters in patients with Parkinson disease in comparison with healthy elderly controls. J Neurology (IF: 3.0) 252:936-43.
Hornyak M, Kopasz M, Rodenbeck A, Hajak G, Riemann D, Voderholzer U (2005) Influence of low –dose doxepin on periodic leg movements in sleep in primary insomnia patients. Somnologie (IF: 0,2) 9: 111 – 115
Jordan W, Reinbacher A, Cohrs S, Grunewald RW, Mayer G, Rüther E, Rodenbeck A (2005) Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides (IF: 2,7) 26, 1654-60
Jordan W, Tumani H, Cohrs S, Rodenbeck A, Rüther E, Bechthold J, Mayer G (2005) Narcolepsy: Increased L-PGDS (-trace) levels correlate with excessive daytime sleepiness but not with cataplexy. J Neurol (IF: 3,0) 252: 1372 – 1378
Kalus P, Slotboom J, Gallinat J, Mahlberg R, Cattapan-Ludewig K, Nyffeler T, Buri C, Federspiel A, Kunz D, Schroth G, Kiefer C (2005). Examining the Gateway to the Limbic System with Diffusion Tensor Imaging: The Perforant Pathway in Dementia. Neuroimage (IF: 5.6) 30: 713-20.
Lang UE, Hellweg R, Bajbouj M, Lenzen KP, Sander T, Kunz D, Gallinat J (2005). Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (IF: 3.6) 180:95-9.
Meier A, Mollenhauer B, Cohrs S, Rodenbeck A, Jordan W, Meller J, Otto M (2005) Normal hypcretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with huntington’s disease. Brain Res (IF: 2,3) 1063: 201 – 203
Meier A, Neumann A-C, Jordan W, Huether G, Rodenbeck A, Rüther E, Cohrs S (2005) Ziprasidone reduces cortisol excretion in healthy subjects. Br J Pharmacol (IF: 3,8) 60: 330-336
Rodenbeck A, Hajak G, Meier A, Cohrs S, Jordan W (2005) Psychoneuroendokrine Pathomechanismen der psychophysiologischen Insomnie. Somnologie (IF: 0,2) 9: 21 – 32
Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A (2005) Ghrelin Stimulates Appetite, Imagination of Food, GH, ACTH, and Cortisol, but does not Affect Leptin in Normal Controls. Neuropsychopharmacology (IF: 4.9) 30(6):1187-92
2004:
Cohrs S, Guan Z, Pohlmann K, Jordan W, Pilz J, Rüther E, Rodenbeck A (2004) Nocturnal urinary dopamine excretion is reduced in otherwise healthy subjects with periodic leg movements in sleep. Neurosci Lett (IF: 2,1) 360(3): 161-164
Cohrs S, Pohlmann K, Guan Z, Jordan W, Meier A, Huether G, Ruther E, Rodenbeck A (2004) Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology (IF: 3,6) 174: 414 – 420
Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, Rüther (2004): Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (IF: 3,6) 174(3): 421-429
Danker-Hopfe H, Kunz D, Gruber G, Klösch G, Lorenzo JL, Himanen SL, Kemp B, Penzel T, Röschke J, Dorn H, A Schlögl A, Trenker A, Dorffner G (2004). Interrater reliability between scorers from eight european sleep labs in subjects with different sleep disorders. J Sleep Res (IF: 3.5) 13:63-9.
Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, Von Ahsen N, Rüther E, Kornhuber J, Bleich S (2004) CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm (IF: 2,9)111(6): 683-689
Jordan W, Tumani H, Cohrs S, Eggert S, Rodenbeck A, Brunner E, Rüther E, Hajak G (2004) Prostaglandin-D-synthase (beta-trace) in healthy human sleep. Sleep (IF: 5,1) 27: 867-74
Kirov R, Kinkelbur J, Heipke S, Kostanecka-Endress T, Westhoff M, Cohrs S, Rüther E, Hajak G, Banaschewski T, Rothenberger A (2004): Is there a specific polysomnographic sleep pattern in children with attention deficit/hyperactivity disorder? J Sleep Res (IF: 3,5) 13, 87-93
Kunz D, Mahlberg R, Müller C, Tilmann A, Bes F (2004). Melatonin in patients with reduced REM sleep duration: Two randomized controlled trials. J Clin Endocrinol Metab (IF: 5.8) 89:128-34.
Kunz D (2004). Chronobiotic protocol and circadian sleep propensity index: New tools for clinical routine and research on melatonin and sleep. Pharmacopsychiatry (IF: 2.8)37:139-46.
Mahlberg R, Kunz D, Sasse J, Kirchheiner J (2004). Serotonine syndrome with tramadol and citalopram in a patient heterozygous for deficient CYP2D6 and CYP2C19 alleles. Am J Psych (IF: 8.3) 161:1129.
Mahlberg R, Kunz D, Sutej I, Kühl KP, Hellweg R (2004). Melatonin treatment of day-night rhythm disturbances and sundowning in Solution for Automatic Sleep disease: An open-label pilot study using actigraphy. J Clin Psychopharmacol (IF: 4.6) 24:456-9.
(Publikationen vor Gründung der AG 2004 sowie Buchartikel etc. finden sich im Anschluss an die individuellen CVs.) |